MedTrace Logo

US Guided Erector Spinae Plane Block in Breast Cancer Surgery: Analgesia, Spread and Immunomodulation

NCT04796363 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-04-11

No results posted yet for this study

Summary

Prospective interventional study

Conditions

Interventions

PROCEDURE

Erector Spinae Plane Block with Bubivacaine

Erector Spinae Plane Block with Bubivacaine 0.25% or 0.125% before breast cancer surgery

PROCEDURE

Standard General Anaesthesia

Standard General Anaesthesia without ESPB

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Emad Eldin Abd El Monem Arida, Professor · University of Alexandria

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-25
Primary Completion
2022-01-11
Completion
2022-01-21

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04796363 on ClinicalTrials.gov